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Glycine receptors (GlyRs) are important mediators of fast inhibitory neurotransmission
in the mammalian central nervous system. Their function is controlled by multiple
cellular mechanisms, including intracellular regulatory processes. Modulation of GlyR
function by protein kinases has been reported for many cell types, involving different
techniques, and often yielding contradictory results. Here, we studied the effects of
protein kinase C (PKC) and cAMP-dependent protein kinase A (PKA) on glycine induced
currents in HEK293 cells expressing human homomeric α1 and heteromeric α1-β GlyRs
using whole-cell patch clamp techniques as well as internalization assays. In whole-cell
patch-clamp measurements, modulators were applied in the intracellular buffer at
concentrations between 0.1 µM and 0.5 µM. EC50 of glycine increased upon application
of the protein kinase activators Forskolin and phorbol-12-myristate-13-acetate (PMA)
but decreased in the presence of the PKC inhibitor Staurosporine aglycon and the PKA
inhibitor H-89. Desensitization of recombinant α1 receptors was significantly increased
in the presence of Forskolin. Staurosporine aglycon, on the other hand decreased
desensitization of heteromeric α1-β GlyRs. The time course of receptor activation was
determined for homomeric α1 receptors and revealed two simultaneous effects: cells
showed a decrease of EC50 after 3–6 min of establishing whole-cell configuration. This
effect was independent of protein kinase modulators. All modulators of PKA and PKC,
however, produced an additional shift of EC50, which overlay and eventually exceeded
the cells intrinsic variation of EC50. The effect of kinase activators was abolished if
the corresponding inhibitors were co-applied, consistent with PKA and PKC directly
mediating the modulation of GlyR function. Direct effects of PKA- and PKC-modulators
on receptor expression on transfected HEK cells were monitored within 15 min of
drug application, showing a significant increase of receptor internalization with PKA
and PKC activators, while the corresponding inhibitors had no significant effect on
receptor surface expression or internalization. Our results confirm the observation that
phosphorylation via PKA and PKC has a direct effect on the GlyR ion channel complex
and plays an important role in the fine-tuning of glycinergic signaling.
Keywords: glycine receptor, PKA, PKC, activators/inhibitors of phosphorylation, whole-cell currents, modulation
kinetics, receptor internalization
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INTRODUCTION
Neuronal glycine receptors (GlyRs), together with GABAA
receptors, mediate fast inhibitory neurotransmission in the
mature central nervous system (Breitinger and Becker, 2002).
GlyRs mediate chloride influx that causes hyperpolarization of
the postsynaptic cell, resulting in an inhibitory postsynaptic
potential (Dutertre et al., 2012). Native GlyRs are composed
of two different subunits GlyR α (48 kDa) and β (58 kDa).
Four different α subunits, α1-α4 and one β subunit are known
to date (Breitinger, 2014), encoded by their respective genes
GLRA1–4 and GLRB (Matzenbach et al., 1994). In addition,
α-subunits can form functional homomeric ion channels
while β-subunits are thought to be responsible of synaptic
anchoring without having ion-channel function of their own
(Breitinger and Becker, 2002; Grudzinska et al., 2005). Each
subunit consists of a large N-terminal extracellular domain,
four transmembrane segments (TM1–4), a long intracellular
loop that connects TM3 and TM4 (TM3–4), as well as a
short extracellular C-terminus (Breitinger, 2014; Figure 1).
The intracellular loop linking the TM3–4 domains consists
of about 100 residues and exhibits the highest degree of
sequence variability among the GlyR family. It contains
sites involved in receptor modulation and interaction with
intracellular proteins and cytoskeletal structures (Breitinger and
Becker, 2002), including potential targeting sites for protein
kinases and/or phosphatases (Smart, 1997). Regulation of
GlyR function by phosphorylation has indeed been observed,
including altering channel properties, receptor expression,
mobility or localization (Ruiz-Gómez et al., 1991; Vaello
et al., 1994; Gentet and Clements, 2002; Velázquez-Flores
and Salceda, 2011; Huang et al., 2015; Langlhofer and
Villmann, 2016). The two most important kinases involved in
phosphorylation of ion channel receptors are protein kinase
C (PKC) and cAMP-dependent protein kinase A (PKA). The
specific phosphorylation sites and the resulting effects on GlyR
function have been explored in different cell types using different
techniques and often yielded inconsistent and even contradictory
results.
Here, we studied the effects of PKA and PKC modulators
on inhibitory GlyRs expressed in HEK293 cells. Stimulation
of PKA and PKC by Forskolin and phorbol-12-myristate-
13-acetate (PMA), respectively, gave higher EC50 values of
glycine, while inhibition of both kinases using H-89 (PKA)
and Staurosporine aglycon (PKC) led to a decrease of EC50.
Effects of kinase modulators were concentration-dependent and
developed fully within 5–10 min after intracellular application.
None of the kinase modulators had an immediate effect on
maximum current responses. However, When the effects of
PKA- and PKC activators was followed over 10 min, a significant
reduction of Imax was observed compared to controls, while
Imax was slightly increased relative to control in presence of
kinase inhibitors. PKA modulators had no effect on GlyR
trafficking, while stimulation of PKC by PMA accelerated
receptor internalization and lowered cell surface expression
of recombinant GlyRs. The opposite was observed with the
PKC-inhibitor Staurosporine aglycon. Thus, phosphorylation
was confirmed to be a specific and relevant modulatory element
of GlyR activity.
MATERIALS AND METHODS
Cell Culture and Transfection
HEK293 cells were grown in 10 cm tissue culture Petri dishes
in Eagle minimal essential medium (Sigma-Aldrich Chemie
GmbH, Munich, Germany) supplemented with 10% FBS
(Invitrogen, Karlsruhe, Germany) and penicillin/streptomycin
(Sigma-Aldrich Chemie GmbH, Munich, Germany) at
5% CO2 and 37◦C in a water saturated atmosphere. For
electrophysiological experiments, cells were plated on poly-L
lysine treated glass coverslips in 6 cm dishes. Transfection
was performed 1 day after cell passage using Gen-Carrier
(Epoch Lifesciences, Sugarland, TX, USA): 1.3 µg of receptor
DNA, 1.3 µg of green fluorescent protein DNA, and
2.6 µl GenCarrier were used, following the manufacturer’s
instructions. Measurements were performed 2–4 days after
transfection. HEK293 cells used for protein expression and
internalization analysis were transfected using a modified
calcium phosphate precipitation method. In brief, a mixture
of plasmid DNA, CaCl2 (2.5M), 0.1× TE buffer and 2× HBS
(50 mM HEPES, 12 mM glucose, 10 mM KCl, 280 mM NaCl,
1.5 mM Na2HPO4) was applied onto the cells for 6 h. A
GlyR α1 to GlyR β ratio of 1:2 was used for co-expression.
Transfection medium was replaced by fresh medium after 6 h.
Immunocytochemical stainings were always done 24 h after
transfection, biotinylation experiments were performed 48 h
after transfection.
Receptor Biotinylation
For biotinylation, transfected HEK293 cells transiently
expressing the GlyR α1 or co-expressing GlyR α1-β were
incubated with PKA or PKC modulators for 16 h. Surface
proteins were labeled with 1 mg/ml EZ-Link Sulfo-NHS-LC-
Biotin (sulfosuccinimidyl-6-[biotin-amido] hexanoate; Thermo
Fisher Scientific, Waltham, MA, USA). After cell lysis, biotin-
labeled protein was removed using streptavidin agarose beads
(Thermo Fisher Scientific, Waltham, MA, USA). Total protein,
surface protein and intracellular proteins were subjected to
SDS-PAGE and Western Blotting.
Immunostaining of Western Blots
For protein separation, 11% polyacrylamide gels were used.
Gels were run at 150 V for 90 min. Proteins were transferred
to a nitrocellulose membrane (GE Healthcare, Freiburg,
Germany) using a wet blot transfer system (Bio-Rad, Hercules,
CA, USA). For GlyR protein transfer, 2 h at 200 mA
were used. Cadherin transfer required overnight blotting at
100 mA. Membranes were blocked for 1 h with 5% BSA in
TBS-T (TBS with 1% Tween 20). Primary antibodies (pan-
α antibody for GlyRs, MAb4a, Synaptic Systems, Göttingen,
Germany, 1:500 in TBS-T and pan-cadherin, Cell Signaling
Technology, Danvers, MA, USA, 1:1.500 in TBS-T) were
incubated overnight at 4◦C. Signals were detected using
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FIGURE 1 | Structure of glycine receptor (GlyR). (A) Topology of the GlyR α1 subunit showing the long extracellular domain, four transmembrane domains
TM1–4 and the long intracellular loop connecting TM3 and TM4. The protein kinase C (PKC) consensus phosphorylation sequence is located in the intracellular
TM3–4 loop, with residue Ser391 marked in red. (B) Electron cryomicroscopy structure of GlyR α1, adapted from Du et al. (2015). Unfortunately, the structures
available do not include the flexible TM3–4 loop.
SuperSignal West Pico (Thermo Fisher Scientific, Waltham,
MA, USA).
Receptor Internalization
To stain internalized GlyRs, GlyR α1 was cotransfected
with GlyR β into HEK293 cells grown on glass cover
slips. Internalization experiments were performed 24 h post-
transfection. Live cells co-expressing GlyR α1-β receptors
were labeled with the α1-specific monoclonal antibody Mab2b
(1:500 in Earle’s minimal essential medium for 1 h at
4◦C). Earle’s minimal essential medium was supplemented
with 10% fetal calf serum, 200 mM GlutaMAX, 100 mM
sodium pyruvate, and 50 U/ml penicillin/streptomycin (Thermo
Fisher Scientific, Waltham, MA, USA). Mab2b was purchased
from Synaptic Systems, Göttingen, Germany. Following three
washing steps in phosphate-buffered saline (PBS, pH 7.4),
cells were incubated with goat-anti-mouse-Cy3 secondary
antibody again for 1 h at 4◦C (dilution of secondary
antibody 1:500 in Earle’s minimal essential medium, Dianova,
Hamburg Germany). Glass cover slips with pre-labeled GlyRs
were transferred into a 24-well plate containing 500 µl
of Earle’s minimal essential medium with PKA and PKC
modulators (200 nM final concentration each; Forskolin,
H-89, PMA, Staurosporine aglycon, all from Sigma-Aldrich
Chemie GmbH, Munich, Germany). Cells were incubated with
modulators for 15 min to allow receptor internalization. Time
point zero (0 min) was taken as a negative internalization
control to ensure health of HEK293 cells (pre-labeling of
GlyRs at 4◦C inhibits internalization). Following incubation
with PKA and PKC modulators, cells were stained with
a second secondary antibody (donkey-anti-goat-Dyelight488,
1:250 in Earle’s minimal essential medium, Dianova, Hamburg,
Germany) for 30 min at 4◦C to label receptor retained at the
cellular surface. Cells were fixed with 4% paraformaldehyde, 4%
sucrose in PBS for 15 min at 4◦C, washed three times in PBS
and stained with 4′,6-diamidino-2-phenylindole (DAPI, Thermo
Fisher Scientific, Waltham, MA, USA) to label the cell nuclei for
5 min at 4◦C (1:5000 in PBS). Coverslips were washed again with
PBS and Aqua Dest and mounted on glass slides using mowiol.
Confocal Microscopy, Image Acquisition
The images were obtained using an inverted Olympus
IX81 microscope equipped with an Olympus FV1000 confocal
laser scanning system, a FVD10 SPD spectral detector and
diode lasers of 495 nm (Alexa488) and 550 nm (Cy3; Olympus,
Tokyo, Japan), and an Olympus UPLSAPO 60× (oil, numerical
aperture: 1.35) objective. Adobe Photoshop (Adobe, San
Jose, CA, USA) or ImageJ (1.51)/Fiji1 were used for image
analysis.
Electrophysiological Recordings and Data
Analysis
Whole-cell recording experiments were performed using
a HEKA EPC10 amplifier (HEKA Electronics, Lambrecht,
Germany) controlled by Pulse software (HEKA). Recording
pipettes were pulled from borosilicate glass (World Precision
1https://imagej.net/ImageJ
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FIGURE 2 | Whole-cell current recordings. (A) Glycine induced currents in HEK293 cells transfected with GlyR α1 or GlyR α1-β in absence of protein kinase
modulators (control), with protein kinase A (PKA) activator Forskolin (Forsk) and inhibitor H-89, as well as PKC activator phorbol-12-myristate-13-acetate (PMA) and
inhibitor Staurosporine aglycon (Stau). Modulators were added to the intracellular buffer at a concentration of 0.5 µM. (B) Desensitization behavior of each single cell
was studied. Fraction of desensitization was calculated by dividing Idesen/Imax. The number of cells showing desensitizing currents (Idesen/Imax > 0.25) out of the total
number of tested cells is shown above each column (#). Significance levels (one-way ANOVA) are indicated (∗p < 0.05, ∗∗p < 0.01, n.s., not significant).
Instruments, Berlin, Germany) using a Sutter P-97 horizontal
puller (Sutter, Novato, CA, USA). Pipettes routinely had an
open tip resistance of 2–4 MΩ. HEK293 cells had a membrane
capacitance of 3–7 pF. Series resistance, as well as slow and
fast capacitance were compensated using the EPC10 circuitry.
The different protein kinase modulators were dissolved in
intracellular buffer at a concentration of 0.5 µM. For studies
of concentration- and time-dependence, kinase modulators
were used at concentrations of 0.1 µM and 0.25 µM. Current
responses were measured at room temperature (21–23◦C) at a
holding potential of −50 mV. Solutions were applied using an
Octaflow system (NPI electronics, Tamm, Germany), where cells
were bathed in a laminar flow of buffer, giving a time resolution
for solution exchange and re-equilibration of about 100 ms.
The external buffer consisted of 135 mM NaCl, 5.5 mM KCl,
2 mM CaCl2, 1.0 mMMgCl2 and 10 mM Hepes (pH adjusted to
7.4 with NaOH); the internal buffer was 140 mM CsCl, 1.0 mM
CaCl2, 2.0 mM MgCl2, 5.0 mM EGTA and 10 mM Hepes (pH
adjusted to 7.2 with CsOH). Dose response data was fitted to the
Hill equation
Iglycine
Isat
= [Glycine]
nHill
[Glycine]nHill + EC50nHill
using a nonlinear algorithm in Microcal Origin. Here, Iglycine is
the current amplitude at a given glycine concentration, Isat is
the maximum current amplitude at saturating concentrations
of glycine, EC50 is the glycine concentration at half-maximal
current responses, and nHill is the Hill coefficient. Currents
from each individual cell were normalized to the maximum
response at saturating glycine concentrations. Significance
of differences between EC50 values were determined using
one-way ANOVA with p ≤ 0.05 (∗) and p ≤ 0.01 (∗∗)
taken as significant. In all experiments, EC50 values were
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FIGURE 3 | Electrophysiological characterization of glycinergic currents upon protein kinase modulation. Dose-response curves of glycine induced currents in
HEK293 cells transfected with GlyR α1 or GlyR α1-β in absence (control) and presence of kinase modulators applied in the intracellular buffer. (A) Control: solid
squares, solid line; 0.5 µM Forskolin (Forsk): open circle, dashed line; 0.5 µM H-89: open up triangle, dash-dotted line; 0.5 µM PMA: open diamond, dashed line;
0.5 µM Staurosporine aglycon (Stau): open down triangle, dash-dotted line. All curves were fitted according to the Hill equation. Curves show a rightward shift of the
dose-response curve in case of activation due to Forskolin or PMA treatment and a left shift in case of inhibition due to H-89 or Staurosporine aglycon treatment.
(B) Single cell EC50 data of control (black), PKA and PKC activator (blue) and PKA and PKC inhibitor (red). (C) Summary of whole-cell current characteristics for PKA
and PKC modulation. Significance levels for the comparison of EC50 (p-values, one-way ANOVA) are indicated (∗p ≤ 0.05, ∗∗p ≤ 0.01, n.s., not significant). All
changes in EC50 values were significant except PMA treatment for heteromeric α1-β GlyRs. Here we detected an increase in EC50 values, however due to the daily
variability in EC50 values this effect was not statistically significant. (D) Simultaneous intracellular application of PKA modulators. Forskolin and H-89, and PKC
modulators PMA and Staurosporine aglycon. All modulators were used at a concentration of 0.25 µM. Left panel: concentration-response curves: solid squares:
control, no modulators; open circles: Forskolin/H-89; open triangles: PMA/Staurosporine aglycon. Right panel: summary of results in a bar graph. No significant
changes from control were observed, indicating that indeed action of PKA- and PKC agonists were counteracted by inhibitors (n.s., not significant).
determined for each individual cell from a non-linear fit of
dose response data to the logistic equation. An unweighted
average ± standard error (SEM) was calculated from all
individual EC50 values, without considering the fitting
errors.
For time course analysis, a series of EC50 data was recorded
from each cell. The first concentration-response curve, defined as
t = 0, was recorded immediately after establishing the whole-cell
configuration and positioning the cell in front of the delivery
tube. The dead time did not exceed 2 min. Further recordings
were made at t = 3 min, t = 6 min and t = 10 min (not attained
with all cells). Time-independent recordings were taken at t = 0,
and values of EC50 and Imax in the presence of PKA- or PKC
modulators were normalized to control (no modulator). For
time course analysis, responses were normalized to the control
value at t = 0. Patch-clamp experiments were carried out on
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different dates and using different batches of HEK 293 cells. Since
control EC50 values varied between different days of plating and
between batches of cells, measurements with kinase modulators
were always compared to control measurements recorded on
the same day and from the same batch of cells. Thus, while
individual EC50 values varied between cells, any changes of EC50
induced by kinase modulators could robustly be observed and
quantified.
RESULTS
To investigate the effects of protein kinase modulation on
GlyR-mediated currents, α1 and α1-β GlyR subunits were
expressed in HEK293 cells and studied using whole-cell patch-
clamp recording techniques. Protein kinase activators and
inhibitors were added to the intracellular buffer. Control
measurements were performed in the absence of modulators
(Figure 2). Averaged data from cells expressing GlyR
α1 and GlyR α1-β was used to construct dose response
curves (Figure 3). Glycine EC50 values were determined
for each individual cell and then averaged. EC50 for
glycine was 37.4 ± 3.7 µM (n = 11) and 45.4 ± 6.0 µM
(n = 8) for α1 and α1-β GlyR, respectively (Table 1).
GlyR α1-mediated currents showed no or very slow
desensitization. Responses from heteromeric α1-β GlyRs,
on the other hand, varied from cell to cell, showing both,
fast desensitizing (50%) or slow to non-desensitizing currents
(Figure 2).
Effects of PKA Modulation on GlyR
Currents
PKA activator Forskolin, as well as the inhibitor H-89 were
added to the intracellular buffer separately, at a concentration
of 0.5 µM (Figure 2). Control cells transfected with homomeric
α1 subunits were not desensitizing while heteromeric α1-β
cells showed desensitization in ∼50% of all cells. When H-89
was present in the intracellular buffer, homomeric α1, as well
as heteromeric α1-β receptors gave non-desensitizing current
responses. Forskolin on the other hand, induced a change
to faster desensitization in all cells transfected with either
α1 or α1-β GlyR subunits (Figure 2B). Considering channel
activation, internal Forskolin treatment gave average EC50 values
of 62.6 ± 7.9 µM (n = 9) for α1 and 71.5 ± 4.3 µM
(n = 7) for α1-β GlyRs (Figures 3A,B). Hence, Forskolin
application caused a significant increase in the EC50 value,
while H-89 decreased EC50 values compared to control giving
an EC50 value of 20.5 ± 3.7 µM (n = 8) for α1 GlyRs
and 14.9 ± 1.0 µM (n = 7) for heteromeric α1-β receptors,
both changes were statistically significant (p < 0.05, one-way
ANOVA; Figure 3C).
Effects of PKC Modulation on
GlyR-Mediated Currents
Presence of intracellular PMA had no effect on receptor
desensitization, in contrast to fast desensitization induced by
the PKA activator Forskolin. When Staurosporine aglycon
was present glycine induced currents showed slow or no
desensitization for both, α1 and α1-β receptors. For comparison,
unmodified α1 GlyR was non-desensitizing, while α1-β
subunits showed 50% desensitizing cells. Thus, significant
differences were only observed for α1-β receptors (Figure 2B).
EC50 values for glycine were increased after intracellular
application of 0.5 µM PMA compared to untreated cells.
These changes were statistically significant for α1 receptors,
but not for heteromeric α1-β subunits. The EC50 values
were 63.0 ± 5.0 µM (n = 7) and 54.0 ± 4.6 µM (n = 8)
for α1 GlyRs and α1-β GlyRs, respectively (Figure 3C). The
PKC inhibitor Staurosporine aglycon resulted in a decrease
of half maximum values of α1 (EC50 = 14.3 ± 1.6 µM,
n = 8), and α1-β receptors (EC50 = 22.6 ± 1.3 µM, n = 8;
Table 1, Figure 3), both changes being statistically significant
(p< 0.01).
We noticed that PKA and PKC inhibitors weakened the
HEK293 cells more than the activators. When the intracellular
concentration of H-89 or Staurosporine aglycon was raised to
1 µM, cells did not survive.
To test if the observed shifts in GlyR responses were
indeed due to changes in PKA- and PKC modulation, we
performed a separate experiment where kinase agonist and
antagonist were applied simultaneously (Figure 3D). To avoid
cell damage, this experiment was performed using 0.25 µM
of each drug, Forskolin and H-89 (PKA), or PMA and
Staurosporine aglycon (PKC). EC50 of GlyR control currents
(no modulator) was 20.4 ± 2.7 µM (n = 3), in presence
of 0.25 µM Forskolin and 0.25 µM H-89, EC50 was 21.3 ±
1.7 µM (n = 3), while in presence of 0.25 µM PMA and
TABLE 1 | Summary of electrophysiological data.
EC50 (µM) nH Imax (nA) Fraction of desensitizing cells N
PKA Control α1 37.4 ± 3.7 2.52 ± 0.22 2.19 ± 0.35 0.02 ± 0.02 11
α1-β 45.4 ± 6.0 1.82 ± 0.16 1.19 ± 0.37 0.41 ± 0.14 8
Forskolin α1 62.6 ± 7.9 2.20 ± 0.26 1.20 ± 0.24 0.57 ± 0.12 9
α1-β 71.5 ± 4.3 1.95 ± 0.14 0.99 ± 0.24 0.52 ± 0.07 7
H-89 α1 20.5 ± 3.7 2.10 ± 0.27 1.91 ± 0.57 0.07 ± 0.03 8
α1-β 14.9 ± 1.0 2.31 ± 0.21 1.37 ± 0.28 0.19 ± 0.09 7
PKC PMA α1 63.0 ± 5.0 1.70 ± 0.11 2.30 ± 0.74 0.05 ± 0.05 7
α1-β 54.0 ± 4.6 2.00 ± 0.19 1.26 ± 0.27 0.27 ± 0.08 8
Staurosporine aglycon α1 14.3 ± 1.6 1.96 ± 0.17 1.70 ± 0.29 0.10 ± 0.05 8
α1-β 22.6 ± 1.3 1.82 ± 0.12 1.11 ± 0.20 0.06 ± 0.04 8
All values are mean ± SEM.
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FIGURE 4 | Time- and concentration-dependence of PKA and PKC modulation. PKA- and PKC-modulators were applied in the patch clamp pipette at
concentrations of 0.1 µM, 0.25 µM and 0.5 µM (data at 0.5 µM are the same as in Figures 2, 3). (A) EC50 values of the first measurement after entering the patch
(t = 0) were compared. All EC50 values in the presence of modulators were normalized to control (intracellular buffer without additions) that were measured in the
same time period. (B) Changes of glycine EC50 upon PKA and PKC modulation were followed up to 10 min after the first recording (see “Materials and Methods”
section) for modulator concentrations of 0 µM (control), 0.1 µM and 0.25 µM. Solid squares, solid line: control; open squares, dashed line: 0.1 µM modulator; open
crossed squares, dash-dotted line: 0.25 µM modulator. EC50 values at t = 0 were normalized to control in the absence of modulators. EC50 values after 3, 6 and
10 min were determined and normalized to the EC50 observed for the same modulator at t = 0. Each time point was measured from 3–5 cells and normalized
currents were averaged. Statistical significance is indicated (∗p < 0.05; ∗∗p < 0.01; n.s., not significant). Note that EC50 changes over time even in absence of
modulators. Addition of PKA- and PKC modulators induces a significant additional shift of concentration-response characteristics.
0.25 µM Staurosporine aglycon, EC50 = 20.3 ± 0.6 µM
(n = 3) was found, all changes were not significant (p > 0.1,
one-way ANOVA). Thus, any shift induced by the PKA-activator
Forskolin, or the PKC-activator PMA was counteracted by the
corresponding antagonists, H-89 and Staurosporine aglycon,
respectively.
Concentration-Dependence of PKA- and
PKC-Modulation of GlyR Activity
There was only a narrow window to study the concentration-
dependence of protein kinase modulation on glycinergic
currents, since concentrations larger than 0.5 µM were not
tolerated by the cells. We chose values between 0.1 µM and
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0.5 µM of each modulator. The effects of all four tested kinase
modulators were indeed concentration dependent. The observed
EC50 values were normalized to control. Shifts at the lowest
concentration of modulators (0.1 µM) were not significant, but
did show a clear trend, while at 0.25µMofmodulator, significant
effects were observed for H-89 and PMA, but not for Forskolin
or Staurosporine aglycon (Figure 4A).
Time Course of GlyR-Mediated Currents
Responses After PKA- and
PKA-Modulation
To identify the time-dependence of any changes in EC50 of
GlyR-mediated currents, we performed a series of experiments
where EC50 was recorded from the same cell after t = 0 min
(i.e., immediately after patching and positioning the cell), and
again after t = 3, 6 and 10 min using 0.1 µM and 0.25 µM of
each kinase modulator in the intracellular pipette (Figure 4B).
Responses from each cell were normalized first to control
values at t = 0 (see Figure 4A) to compensate for the 2-min
dead time between establishing whole cell configuration (start
of modulator activity) and the first recording at t = 0. For
each cell, EC50 values at t = 3, 6 and 10 min were then
normalized to the value at t = 0. Time-dependence revealed two
simultaneous effects: (i) a time-dependent change in receptor
activation where EC50 values were reduced between 3 min and
6 min after the first measurement. This effect was independent of
the absence or presence of kinase modulators; and (ii) distinct
effects of the four protein kinase modulators on GlyR EC50
that were reproducibly observed and were additive to the
first effect. Presence of the PKA-activator Forskolin and the
PKC-activator PMA shifted EC50 towards higher values, while
PKA antagonist H-89, and the PKC-antagonist Staurosporine
aglycon shifted EC50 towards lower values (Figure 4B). Thus,
time course analysis robustly confirmed the effects of protein
kinase modulators on GlyR current responses. It is noted that
the effects of lower concentrations (0.1 µM and 0.25 µM)
became more pronounced at longer time of application
(Figure 4B).
When maximum currents were followed over a time of
10 min and normalized to the values at t = 0, Imax was
significantly reduced (p < 0.05, one-way ANOVA) for control
(no modulator), and also in the presence of 0.25µM intracellular
Forskolin or PMA (Figure 5A). In contrast, changes of Imax at
t = 10 min were not significant in the presence of 0.25 µMH-89,
or Staurosporine aglycon (Figure 5A).
At t = 10 min, Imax was reduced relative to the value at
t = 0 (Figure 5B, right vs. left panel). At t = 0 all protein
kinase modulators were without significant effect when Imax was
normalized to control (no modulator; Figure 5B, left panel).
When compared to control value at t = 10 min, maximum
currents were reduced in the presence of kinase agonists and
increased in presence of protein kinase antagonists (Figure 5B,
right panel).
In case of EC50, effects of kinase modulators were apparent
even at t = 0. Here, kinase agonists Forskolin and PMA
increased EC50, while kinase antagonists H-89 and Staurosporine
FIGURE 5 | Time dependent development of Imax and EC50 after treatment
with PKA and PKC modulators. Changes in Imax and EC50 values were
followed for 10 min after the first current recording. Modulator concentrations
were 0.25 µM. (A) Comparison of Imax values of PKA and PKC modulators
after 0, 3, 6 and 10 min. Imax values were normalized to t = 0. (B) Start
(t = 0 min) and end (t = 10 min) maximum currents of various modulators were
compared to control currents. (C) EC50 values at t = 0 and 10 min were
compared to control values. Half-maximum concentrations of glycine in the
presence of PKA and PKC modulators at t = 0 were normalized to control (no
modulation). Additionally, 10 min data points were normalized to the
corresponding starting EC50 (t = 0). Each data point was measured for at least
three cells and normalized EC50 values were averaged. Statistical significance
is indicated (∗p < 0.05; ∗∗p < 0.01; n.s., not significant).
aglycon had the opposite effect. Kinase-induced changes were
only significant for H-89 and PMA (Figure 5C, left panel).
At t = 10 min, changes of EC50 induced by all PKA- and
PKC-agonists and antagonists were significant (Figure 5C, right
panel). It is noted that the concomitant changes in Imax and
EC50 may be expected for changes of receptor channel gating,
where reduced channel open probability would result in an
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FIGURE 6 | PKA and C activators enhance GlyR internalization. HEK293 cells transfected with GlyRα1-β were pre-labeled with the specific α1 antibody MAb2b and
goat-anti-mouse Cy3-coupled secondary antibody, followed by incubation with PKA activator Forskolin (Forsk), PKA inhibitor H-89, PKC activator PMA and PKC
inhibitor Staurosporine aglycon (Stau) for 0 min and 15 min in cell culture medium at 37◦C and 5% CO2. Retained receptors at the surface were double labeled using
a donkey-anti-goat-Dyelight488 antibody. (A) Representative cells at various time points (0, 15 min) incubated with PKA and PKC activators and inhibitors showing
internalized receptor (red dots), and receptor retained at the cellular surface (yellow dots), control always shows untreated cell (UT). White arrows point to internalized
receptors. Nuclei (blue) were marked by 4′,6-diamidino-2-phenylindole (DAPI). (B) Quantification of internalized receptor (red dots/cell) at two different time points
(0 min = black bars; 15 min = white bars). Averages from five independent experiments ± SEM are given, determined from 16 to 51 cells per condition. Significance
values (one-way ANOVA) ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
increase of EC50 and lowering of Imax, and vice versa for
increased Popen of the channel. Lower values of Imax might,
however, be due to changes in the number of active receptors
on the cell surface. We thus tested whether protein kinase
modulation had an effect on receptor density on the transfected
cells.
Cell Surface Expression and Internalization
Assay
Cell surface expression of GlyR α1 homomers and α1-β
heteromers was determined by biotinylation of cell surface
protein and subsequent discrimination of surface and whole
cell protein by Western Blot analysis (data not shown). Prior
to protein biotinylation, PKA modulators and PKC modulators
were incubated with transfected cells for 16 h. Neither PKA
nor PKC modulators had a significant effect on GlyR α1 and
GlyR α1-β whole cell or surface expression. Local changes in
surface expression might, however, be overlaid by continuous
overexpression of GlyRs in transfected HEK293 cells during the
incubation period of 16 h. Previously, it has been shown that
receptor internalization following PMA treatment starts already
within 15 min (Huang et al., 2007). Therefore, we performed
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short-term receptor internalization experiments using PKA and
PKC modulators. To distinguish internalized receptor from
newly synthesized receptor protein, GlyRs were fluorescence
labeled using an α1-specific antibody at 4◦C followed by a
period of incubation with PKA modulators (Forskolin and H-
89) or PKC modulators (PMA and Staurosporine aglycon) at
37◦C to allow receptor internalization. Internalized receptors
were imaged (Figure 6A) and quantified (Figure 6B) in
comparison to untreated cells. Activators of PKA (Forskolin)
and PKC (PMA) significantly enhanced GlyR internalization
after 15 min (Forskolin 6.9 ± 1.5 dots/cell, p = 9.3E-05; PMA
3.9 ± 0.7 dots/cell, p = 0.006; in comparison to untreated
cells UT 1.7 ± 0.4 dots/cell). In presence of kinase inhibitors
H-89 (PKA) and Staurosporine aglycon (PKC), internalization
was lower compared to the corresponding PKA and PKC
activators. It is noted, that even in presence of the inhibitors,
overall internalization was increased relative to control, but
these increases were not significant (H-89: 4.0 ± 1.0 dots/cell,
p = 0.09; Staurosporine aglycon: 2.3 ± 0.5 dots/cell, p = 0.200;
Figure 6B).
The observed short-term effects of PKA and PKC modulators
on receptor internalization were visible in a similar time
frame to that of electrophysiological recordings, indicating that
kinase modulators were able to induce fast changes of receptor
properties on a time scale of minutes following their application.
DISCUSSION
Phosphorylation of neuronal receptors is an important
mechanism of the regulation of receptor expression and function.
In case of the cys-loop receptor family, phosphorylation sites
have been mainly mapped to the highly variable TM3–4 loop of
the mature protein, where different subunits of the receptor show
various phosphorylation sites. Two kinases are mainly involved
in phosphorylation of the intracellular loop namely, PKC and
cAMP-dependent protein kinase A (PKA). GlyR α1 subunits
isolated from rat spinal cord were shown to be phosphorylated at
Ser391 by PKC in vitro, with the phosphorylated serine residue
located within a distinct PKC phosphorylation consensus
sequence in the cytoplasmic TM3–4 loop (Figure 1; Ruiz-Gómez
et al., 1991). In contrast to PKC, most GlyR α1 subunit isoforms
do not contain consensus sites for PKA phosphorylation. One
exception is the α1ins splice variant containing an 8-amino
acid insert (326SPMLNLFQ333, numbers referring to the mature
protein) in the TM3–4 domain. Here, the first residue of this
insert may serve as a phosphorylation site for PKA (Malosio
et al., 1991; Lynch, 2004). The α1 sequence used in our study
did not contain the insert, thus lacking this potential PKA
phosphorylation consensus sequence. Therefore, the effects
on homomeric α1 glycinergic currents might be mediated by
indirect interactions involving multiple intracellular processes
downstream of PKA activation (Vaello et al., 1994). The
β-subunit, on the other hand contains a PKA consensus
site at position T363 in the TM3–4 domain (Grenningloh
et al., 1990). However, it is not yet determined whether
the α1ins or the β-subunit sites are directly phosphorylated
(Lynch, 2004). The GlyR β-subunit also contains a putative
PKC phosphorylation consensus site at position S389 in
the TM3-4 domain, whose functional status remains to be
confirmed (Grenningloh et al., 1990; Lynch, 2004). Recently,
an additional PKC phosphorylation site was identified in the
β-subunit (Specht et al., 2011). This phosphorylation site (S403)
is located at the end of the TM3–4 and influences the binding
affinity between the receptor and gephyrin. Phosphorylation
of α3 GlyRs, which alters receptor function and its role of in
spinal nociceptive signaling has been well studied and reviewed
previously (Harvey et al., 2004; Zeilhofer, 2005; Han et al.,
2013).
In the literature, the specific phosphorylation sites and
the resulting effects on GlyR function have been explored in
different cell types using different techniques, often yielding
inconsistent and even contradictory results. This can be
attributed to differences in receptor clustering and the presence
of cytoskeletal proteins which seem to affect the accessibility
of receptor phosphorylation sites for the kinases/phosphatases.
Furthermore, it is postulated that these enzymes could exert
a direct action on other modulatory proteins that directly
interact with the receptor, adding to the observed tissue-specific
differences (Lynch, 2004). Some of the contradictory effects of
cAMP-dependent phosphorylation as well as protein kinase C
may be explained by the differential expression of α1ins- and
β-subunits throughout the central nervous system (Legendre,
2001). Here, we investigated the role of protein kinases in the
modulation of glycinergic transmission. We concentrated on
functional aspects using whole-cell patch-clamp technique as
well as GlyR expression.
We used established, specific modulators of PKA and PKC.
For PKA, we used Forskolin, a diterpene from the Indian Coleus
plant (Plectranthus barbatus), which activates adenylyl cyclase,
leading to an increase of cAMP levels, which in turn increases
PKA activity, and H-89, a competitive inhibitor of the ATP
binding site of PKA. PKC activation was done using PMA, a
structural analog of the natural PKC activator diacyl-glycerol.
For PKC inhibition, we used Staurosporine aglycon, a natural
indole antibiotic from Streptomyces staurosporeus, which acts as
competitive inhibitor of ATP binding to PKC.
PKA Modulation of GlyR-Mediated
Currents
The functional effect of PKA activation and inhibition on glycine
induced currents was examined in HEK293 cells expressing
α1 and α1-β GlyRs. For electrophysiological measurements
we applied the modulators in the intracellular medium at
concentrations of 0.5 µM, or at 0.1 µM and 0.25 µM when
time- and concentration-dependence of kinase modulators were
studied in α1 homomeric receptors. Intracellular application
of modulators helped to avoid possible direct effects of the
modulators on the GlyR as has been reported previously
(Wagoner and Pallotta, 1988; Swope et al., 1992) and ensured
rapid action of the respective kinases. The PKA activator
Forskolin caused a significant increase in half maximum
concentration of current activation by glycine for both, α1 and
α1-β receptors, but had no significant effect on maximum
currents. Forskolin, however, affected desensitization behavior
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of α1- and α1-β receptors as glycine-mediated currents from
cells treated with Forskolin showed faster desensitization than
untreated controls. The change to fast desensitization was
significant for homomeric α1 receptors, while for α1-β control
currents partial desensitization (>10% of desensitizing current)
was observed in five out of nine traces, and addition of
Forskolin induced no significant changes. The PKA inhibitor
H-89, on the other hand, reduced EC50 values significantly,
this effect being more pronounced for α1-β variants than for
monomeric α1 subunits. H-89 had no significant effect on
desensitization of homomeric α1 receptors, currents were slow-
or non-desensitizing, similar to untreated controls. Glycine-
induced α1-β currents, on the other hand, were predominantly
non-desensitizing in the presence of H-89, while control currents
were both, desensitizing, or non-desensitizing, varying from
cell to cell. The considerable variability in the desensitization
of neuronal GlyR is known in the literature, but not yet
fully understood (Gielen and Corringer, 2018). Reports in the
literature on activation and inhibition of GlyR function by
PKA are quite contradictory. In periaqueductal gray neurons,
Forskolin inhibited Igly potentiation induced by µ-opioid
agonist D-Ala 2, N-MePhe4, GlyS-ol-enkephalin, while PKA
inhibition by H-89 resulted in a potentiation of Igly (Min
et al., 1996). These effects of Forskolin and H-89 are in
agreement with our observations. Li and Yang (2001) studied
the effect of Forskolin on isolated carp amacrine-like cells,
where Forskolin markedly accelerates desensitization of whole
cell responses but the effect cannot be blocked by PKA
inhibitors like H-89 and H-8. Also, 1,9-dideoxy Forskolin,
an inactive analog of Forskolin accelerates the desensitization
effectively, indicating that changes in desensitization behavior
are not mediated by cAMP-dependent protein kinase. Authors
suggest that Forskolin might act directly on an extracellular
site of the GlyR (Li and Yang, 2001). Similar direct effects
of Forskolin were also reported in intact skeletal muscles,
where Forskolin induced enhancement of desensitization of
the nAChR in a cAMP-independent manner (Wagoner and
Pallotta, 1988). In the present study, Forskolin application was
intracellular, thereby excluding the possibility of an extracellular
binding site responsible for altered desensitization behavior.
Nevertheless, we observed accelerated desensitization after
internal Forskolin treatment suggesting that there must be
an additional aspect—maybe phosphorylation after all—that is
responsible for the observed changes in desensitization. Gentet
and Clements studied phosphorylation on GlyR α1 expressed in
HEK293 cells (Gentet and Clements, 2002). They observed that
phosphorylation accelerated desensitization of glycine induced
currents, in agreement with our data. A further phosphorylation
study on 3H-glycine and 3H-strychnine specific binding to
GlyRs in intact isolated frog retinas showed that specific
binding of both radioligands was reduced 30%–90% after
activation of PKA with 10 µM Forskolin (Salceda and Aguirre-
Ramirez, 2005), in good agreement with reduced receptor
activity after PKA treatment observed in this study. In case
of α2 and α3 receptors, Ser-346, located within the PKA
consensus sequence (R-E-S-R, not present in α1) of the GlyR
α3 intracellular loop has proven to be an essential target
for prostaglandin-E(2)-mediated phosphorylation. Stimulation
of the prostaglandin E2 receptor by PGE2 results in a
cAMP-mediated activation of PKA. Phosphorylation of Ser-346
slowed desensitization and decreased glycinergic currents in
HEK293 cells expressing GlyR α3 and α2 subunits (Heindl et al.,
2007).
GlyR modulation through PKA was described in other
expression systems. Potentiation of chloride currents after PKA
activation was observed in spinal trigeminal neurons (Song and
Huang, 1990), Xenopus oocytes expressing α1 GlyRs (Vaello
et al., 1994), and trigeminal neurons (Gu and Huang, 1998).
Ren et al. (1998) studied cAMP-dependent PKA modulation
of glycine activated chloride currents in single neurons from
rat ventral tegmental area in whole cell patch clamp technique.
The current induced by small glycine concentrations (3–10 µM
glycine) increased spontaneously after internal application of
Mg-ATP. When H-89 was added to the pipette solution, ATP
induced run-up of the glycine current was blocked (Ren et al.,
1998). The contradictory results reported in the literature may
likely be a consequence of differential expression of GlyR
subunits throughout the central nervous system (Legendre,
2001).
PKC Modulation of GlyR-Mediated
Currents
Activation of PKC by PMA resulted in significantly increased
EC50 values for glycine in HEK293 cells expressing α1 receptors
compared to untreated controls. The same tendency was seen
in cells expressing heteromeric α1-β subunits. Here, changes
were not statistically significant but the trend was similar to
that seen in homomeric receptors. PKA and PKC inhibitors
H-89 and Staurosporine aglycon, respectively, reduced GlyR
EC50, changes were significant for both α1 and α1-β subunits.
Similar to PKA modulators, we did not observe any significant
changes in maximum currents. In homomeric α1 receptors
slow desensitization was observed in case of control cells
as well as cells treated with PMA. In α1-β receptors we
observed non-desensitizing as well as fast desensitizing currents
for both, control and PMA treated cells, indicating that
PKC activation by PMA had no effect on desensitization.
Staurosporine aglycon treatment resulted in non- or slowly
desensitizing currents for both, α1 and α1-β receptors. In
case of α1 receptors this was unchanged from controls.
For cells expressing α1-β receptors, on the other hand,
changes in desensitization behavior were statistically significant.
While control cells showed heterogeneous desensitization
behavior that varied from cell to cell, all cells treated
with Staurosporine aglycon gave non-desensitizing currents.
Our observation that receptor function is reduced upon
PKC activation and increased upon PKC inhibition has
been reported previously. GlyR expressed in Xenopus oocytes
injected with mRNA isolated from nervous tissue showed
decreased glycinergic currents after PMA-induced activation
indicating that the PKC system is involved in negative
regulation of the GlyR channel (Vaello et al., 1994). Reduced
responses were also reported when homomeric α1 GlyRs
expressed in Xenopus oocytes were activated by 4-beta-PMA.
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In the presence of Staurosporine aglycon the effect was
inhibited. 4-alpha-PMA, a poor PKC stimulant, did not
affect the glycine currents, indicating that the PKC system
is involved in negative regulation of the GlyR channels
(Uchiyama et al., 1994). PKC activation by PMA was found
to reduce the amplitude of glycine currents, in agreement
with our results (Tapia et al., 1997). The same study,
however, reports that PKA activation potentiates glycine induced
currents, which is in contrast to our findings (Tapia et al.,
1997).
Recently, the effects of receptor phosphorylation on specific
binding of 3H-Gly and 3H-Str were investigated. The binding
of both radioligands was remarkably reduced after phorbol
ester activation in isolated frog retinas (Salceda and Aguirre-
Ramirez, 2005), in agreement with our findings. In a similar
study, specific radioligand binding after PKA or PKC activation
was decreased by 60%–85%, an effect that could be blocked
by specific kinase inhibitors (Velázquez-Flores and Salceda,
2011). The effect of temperature on PKC modulation was
investigated in Xenopus oocytes and HEK293 cells (Machu
et al., 2006). PMA produced a large, reproducible decrease
in the peak amplitude of GABA- and Gly-gated currents
in oocytes. In contrast, PMA was ineffective in modulating
these receptors at room temperature in HEK293 cells. When
electrophysiological experiments were performed at 35◦C in
HEK293 cells, PMA decreased the function of these receptors.
The authors claim that the temperature is an important variable
when studies are performed in HEK293 cells expressing GlyRs
and could be a reason for contradicting results in former studies
(Machu et al., 2006). Enhancement of glycinergic currents upon
PKC activation was observed in rat sacral dorsal commissural
neurons (Xu et al., 1996), hippocampal neurons (Schönrock
and Bormann, 1995) and trigeminal neurons (Gu and Huang,
1998). In summary, neuronal cell type and location seem
to be important parameters that might cause controversial
observations after PKC or PKA modulation (Lynch, 2004).
Furthermore, temperature was suggested as a relevant parameter
for PKC modulation of ligand-gated ion channels (Machu et al.,
2006).
Concentration Dependence and Time
Course of PKA- and PKC-Modulation of
GlyR-Mediated Currents
We noticed that the effects of PKA- and PKC-modulators
on GlyR currents were concentration-dependent. At lower
concentrations of kinase modulators (0.1 and 0.25 µM) changes
were all significant after 10 min of application. Changes of
EC50 were robust and reproducible in all experimental settings.
Time-dependent changes in Imax were only apparent after 10 min
of application of PKA- and PKC-modulators (0.25 µM). The
time dependent reduction of Imax was opposed by PKA and PKC
inhibitors. A concomitant shift of EC50 towards lower values and
increase of Imax would be consistent with increased channel open
probability, i.e., more effective gating (Colquhoun, 1998). While
receptor function is clearly affected by the absence or presence
of PKA- and PKCmodulators, more experiments are required to
identify this as a gating effect.
The effects of PKA- and PKC-agonists (Forskolin and PMA,
respectively) on GlyR currents could be offset by the addition of
the corresponding antagonists, H-89 (PKA) and Staurosporine
aglycon (PKC).
PKA- and PKC-Modulation of GlyR
Internalization
No changes in receptor surface expression were obvious after
long-term (>1 h) incubation with PKA and PKC modulators.
In this situation, the effects of a single application of kinase
modulators will be counterbalanced by the general turnover of
receptor protein. On a shorter time scale, distinct effects of PKA
and PKC modulation could be observed. Activation of either
PKA or PKC by Forskolin or H-89 treatment induced enhanced
receptor internalization after short-term treatment (15 min),
while kinase inhibitors H-89 and Staurosporine aglycon showed
no significant effects. These findings are in agreement with
electrophysiological data: when PKA and PKC activators were
present in the intracellular buffer, a modulation of GlyR currents
was detected within∼10 min.
Evidence for the involvement of protein kinases—especially
PKC—in the regulation of ion channel surface expression
and clustering was described previously for GlyRs, as well
as other members of the ligand-gated ion channel family.
Huang et al. (2007) showed that endocytosis of the GlyR
in HEK293 cells expressing GlyRα1 is mediated by PKC
activation and that it is dynamin-dependent. Further evidence
that supports the involvement of PKC in GlyR surface
expression was a set of immunofluorescent studies done in
spinal cord neurons. Labeling studies were directed towards
PKC and showed a redistribution of the fluorescent signal
towards the cell periphery upon PMA treatment, meaning
that PKC is recruited towards the cell periphery to start
mediating endocytosis (Velázquez-Flores and Salceda, 2011).
Along with reduced specific radioligand binding by 60%–85%
after PKA and PKC activation, Velázquez-Flores and Salceda
(2011) observed reduced GlyR expression in the plasma
membrane by about 50% which was consistent with an
increase of the receptor in the microsomal fraction when
PKA was activated. The collective data indicates increased
receptor endocytosis and reduced cell surface expression as a
result of protein kinase activation, suggesting that PKC plays
an important role in the balance between endocytosed and
surface expressed receptors. Reduced cell surface expression
as a consequence of PKC activation was also shown for
other ligand-gated ion channels like recombinantly expressed
human rho1 GABAC receptors (Filippova et al., 1999), and
recombinant GABAA receptors (Connolly et al., 1999). Similar
studies on NMDA receptors NR1 and NR2 in cultured
hippocampal neurons showed opposite results. Here, 40%–50%
of total NR1 immunoreactivity is found at the cell surface, as
compared to more than 90% of total NR2B immunoreactivity
while metabolic labeling of the cultures with [32P] revealed
that NR2 subunits are highly phosphorylated under basal
conditions, whereas basal phosphorylation of NR1 subunits is
barely detectable (Hall and Soderling, 1997). Internalization
of GABAA receptors in primary cultures of cerebral cortical
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neurons was increased upon PKC activation, as demonstrated
by limited chymotrypsin digestion assays (Herring et al., 2005),
an observation that is in agreement with our data for the
expression of heteromeric α1-β GlyRs in HEK293 cells. It
should be noted that GlyR retrograde trafficking might be
different in neurons where the cytoskeletal anchoring protein
gephyrin is cotransported together with the GlyR complex
enabling GlyR synaptic integration at postsynaptic membranes.
Recent evidence from experiments on murine hippocampal
neurons have shown that gephyrin is itself phosphorylated,
which allows subsequent interaction with different scaffolding
proteins (Zita et al., 2007). These neuron-specific interactions
are expected to be important for GlyR function and surface
clustering.
Our findings show that activation of PKA and PKC
reduces GlyR-mediated currents in a recombinant system.
Inhibition of both kinases has the opposite effect. These effects
are concentration-dependent and occur within minutes of
application. On the same time scale of GlyR currentmodification,
PKA and PKC activators increase internalization of the receptor,
while their corresponding inhibitors have an opposite effect.
Thus, GlyR phosphorylation is an important physiological
regulatory mechanism that is involved in the fine-tuning of
expression, trafficking and ion channel function of GlyRs.
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